Clinical trial
GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients…
NCT00426205 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00426205 |
|---|---|
| Title | GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies |
| Official title | GM-CSF Secreting Leukemia Cell Vaccinations After Allogeneic Non-myeloablative Peripheral Blood Stem Cell Transplantation in Patients With Advanced Myelodysplastic Syndrome or Refractory Acute or Advanced Chronic Myeloid Leukemia |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Brigham and Women's Hospital |
| Status | Completed |
| Study type | Interventional |
| Conditions | Myelodysplastic Syndrome RAEB-I or RAEB-II, Refractory Acute Myeloid Leukemia, Refractory CML Myeloid Blast Crisis |
| Intervention type | Biological |
| Interventions | GM-CSF secreting leukemia vaccine |
| Enrollment | 28 |
| Start date | Jun 1, 2004 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2009 |
| First posted | Jan 24, 2007 |
| Last update posted | Feb 11, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: